摘要:
This invention provides compounds of Formula (I), having the structure 1 where T, Z, X, A, R1, R2a, R2b, R2c, R3, R4, and n are defined herein, or a pharmaceutically acceptable salt thereof which are useful as antineoplastic agents and in the treatment of osteoporosis and polycystic kidney disease.
摘要:
This invention provides compounds of formula 1, having the structure 1 which are useful as inhibitors of protein tyrosine kinase and are antiproliferative agents.
摘要:
This invention provides compounds of Formula (1a)-(1f), II 1 wherein: X, m, n, q, R1, R2, R3, R4, R5, R6, R7, R8, R9, Y, Q, Z, Znull, Znullnull, Znull and J are defined hereinbefore in the specification, which are useful in the treatment of cancer, stroke, myocardial infarction, neuropathic pain, osteoporosis, polycystic kidney disease, autoimmune disease, rheumatoid arthritis, and transplant rejection and process for producing said compounds.
摘要:
This invention provides compounds of Formula (Ia)-(If) 1 wherein: X, R1, and R2 are defined hereinbefore in the specification, which are useful in the treatment of cancer, stroke, osteoporosis, polycystic kidney disease, autoimmune disease, rheumatoid arthritis, and transplant rejection and process for producing said compounds.